Skip to Content
Merck
CN

Target Identification for Antibody Drug Discovery

Identify targets using the most comprehensive set
of genome-wide screening tools available.

HomeIntegrated OfferingsMonoclonal Antibodies (mAbs)Antibody Drug DiscoveryTherapeutic Antibody Target Discovery

 

Target discovery involves the identification of specific genes or proteins that play a key role in disease. We offer a complete set of genome-modifying screening tools, including CRISPR and shRNA modalities, to facilitate target identification for monoclonal antibody screening. These tools can be combined with a wide array of cellular and biochemical tools to fast-track target validation and therapeutic development. 


Therapeutic Antibody Target Discovery

Therapeutic Antibody Target Discovery

Selecting the Right Target

The process of target discovery typically involves several stages, starting with a comprehensive analysis of the disease pathology and its underlying molecular mechanisms. Our functional genomic screening tools enable modulation of hundreds or thousands of genes in a single experiment to identify therapeutic targets, facilitating selection of the optimal target.


Related Categories

GenElute™-E single-spin DNA purification kit
More Sustainable and High Performing Genomic Purification Kits

Single spin purification of DNA and RNA, with less plastic and liquid waste.

Gel electrophoresis equipment including mPAGE® mini gel tanks, gel casters, drying rack, pouring plates, and combs
Protein Gel Electrophoresis and Transfer Equipment

Tanks, blotting systems, and power supplies for protein gel electrophoresis.


Related Articles


Related Video


Explore our Products & Services

Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?